Biological sample collection apparatus and methods
The microfluidic apparatus with passive venting channels and capillary pumps addresses the limitations of existing systems by enabling reliable, low-cost, and portable droplet generation and separation for biological samples, suitable for diverse biofluids and point-of-care diagnostics.
Patent Information
- Application Number
- PCT/CA2026/050679
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-11
- Publication Date
- 2026-11-12
AI Technical Summary
Existing droplet microfluidic systems rely on active pumps and bulky actuators, limiting scalability, portability, and usability for biological sample collection.
A microfluidic apparatus with a hydrophilic bottom and top layer and hydrophobic adhesive layers, featuring passive venting channels, capillary pumps, and stop valves, enabling droplet generation and separation without external pressure or actuation, fabricated using scalable multilayer lamination.
Enables reliable, bubble-free droplet generation and separation with fixed droplet positioning, suitable for diverse biofluids, facilitating high-throughput, low-cost production and integration into wearable or swallowable devices for point-of-care diagnostics.
Smart Images

Figure CA2026050679_12112026_PF_FP_ABST
Abstract
Description
BIOLOGICAL SAMPLE COLLECTION APPARATUS AND METHODSCross-Reference to Related Application
[0001] This application claims the benefit of priority of U.S. Provisional Patent Application No. 63 / 803,080 filed on May 9, 2025, which is hereby incorporated herein by reference in its entirety.Technical Field
[0002] The present disclosure relates to collection of samples of biological fluids. Particular embodiments relate to apparatus and methods for collecting a biological fluid sample and separating it into a plurality of individual droplets.Background
[0003] Droplet microfluidics has revolutionized many biomedical applications, but existing systems often rely on active pumps, bulky actuators, and complex setups that limit scalability, portability, and usability.
[0004] The inventors have determined a need for improved apparatus and methods for collecting biological samples.Summary
[0005] One aspect of the present disclosure provides an apparatus for separating a liquid sample into a plurality of individual droplets, the apparatus comprising a bottom layer and a top layer, each constructed from a hydrophilic material, and a plurality of adhesive layers disposed between the bottom layer and the top layer, each adhesive layer constructed from a hydrophobic material. In this aspect, the top layer has openings formed therein defining a sample inlet and a vent, and the plurality of adhesive layers have openings formed therein defining a microfluidic circuit comprising: an inlet chamber in fluid communication with the sample inlet; an outlet chamber in fluid communication with the vent; a main flow channel connected between the inlet chamber and the outlet chamber; a plurality of microwells, each microwell having a first end and a second end, the first end connected to the main flow channel; and a passive ventingchannel network providing fluid communication between the second end of each of the plurality of microwells and a downstream portion of the main flow channel between a last microwell of the plurality of microwells and the outlet chamber.
[0006] In some embodiments, the main flow channel comprises a bubble trap between the plurality of microwells and the downstream portion.
[0007] In some embodiments, the second end of each of the plurality of microwells is connected to the passive venting channel network through a stop valve.
[0008] In some embodiments, the apparatus comprises a wicking pad disposed within the outlet chamber.
[0009] In some embodiments, the plurality of adhesive layers comprise a lower adhesive layer in contact with the bottom layer, an upper adhesive layer in contact with the top layer, and at least one intermediate adhesive layer between the upper and lower adhesive layers.
[0010] In some embodiments, the passive venting channel network is defined by openings in only the at least one intermediate adhesive layer.
[0011] In some embodiments, for each microwell, a distance between the first end and the second end is shorter in the upper adhesive layer than in the lower adhesive layer and the at least one intermediate adhesive layer.
[0012] In some embodiments, the microwells on each side of the main channel are arranged in sequence, and the passive venting channel network comprises a trigger valve connected between the second ends of adjacent microwells in each sequence, such that the microwells on each side of the main channel are filled sequentially.
[0013] In some embodiments, the top layer has an opening defining a second inlet.
[0014] In some embodiments, the top layer has openings defining a plurality of vents, and the microfluidic circuit comprises a plurality of main flow channels, each having a plurality of microwells extending therefrom and an associated outlet chamber in fluid communication with one of the plurality of vents.
[0015] In some embodiments, the microfluidic circuit further comprises a capillary pump formed by interconnected channels of varying surface energies and geometries.The capillary pump is configured to passively control the timing and rate of fluid movement through the device without requiring external pressure or actuation.
[0016] In some embodiments, the capillary pump includes at least one high capillary force channel connected to a retention region. The combination of these regions regulates fluid movement through defined capillary pressure gradients and enables staged sample progression.
[0017] In some embodiments, the microfluidic circuit further comprises one or more passive valve structures selected from retention valves, burst valves, stop valves, or trigger valves. Each valve is formed by a change in channel geometry or surface property and is configured to block or delay fluid flow until a defined pressure threshold is met.
[0018] In some embodiments, at least one valve structure is created by partially or fully cutting through selected adhesive layers, resulting in a depth-based or materialbased transition that determines the bursting pressure required for flow.
[0019] In some embodiments, each microwell is connected to the downstream portion of the main channel through a flow control interface formed by a junction of channels with distinct cross-sectional shapes, surface energies, or material properties, enabling precise regulation of droplet separation and timing.
[0020] In some embodiments, one or more microfluidic channels are fabricated using a partial-depth cutting method that ablates adhesive without perforating the full thickness of the layer, thereby eliminating the need for alignment across multiple patterned layers and simplifying fabrication.
[0021] In some embodiments, the microfluidic device is fabricated using a scalable multilayer lamination process compatible with roll-to-roll manufacturing, comprising at least three functional layers: a bottom hydrophilic film layer for fluid guidance, one or more intermediate adhesive or patterned spacer layers to define fluidic channels, and a top hydrophilic cover layer for sealing and structural support. The device avoids the use of injection molding, PDMS casting, or photolithography, enabling low-cost, high-throughput production using commercially available polymer sheets and adhesive films.
[0022] In some embodiments, the microfluidic device functions as a digital loop-mediated isothermal amplification (dLAMP) cartridge fabricated from optically transparent, non-autofluorescent, and thermally stable polymer films compatible with roll-to-roll manufacturing. The cartridge enables compartmentalized amplification within microwells and is configured to interface with external fluorescence detection systems for high-sensitivity nucleic acid quantification.
[0023] In some embodiments, the passive venting channel network is implemented in a series or parallel configuration and includes two or more sample inlets and two or more outlet chambers. The venting paths are configured to support sequential or simultaneous delivery of multiple fluid phases.
[0024] In some embodiments, the series venting configuration at their second ends include variable-length or variable-resistance pathways to delay access to venting, thereby controlling the timing of microwell filling and preventing premature droplet merging.
[0025] In some embodiments, the microwells are pre-functionalized with biological or chemical reagents, including antibodies, enzymes, aptamers, peptides, or primers, and are configured to enable chemical reaction, drug screening, or biomarker analysis under static or dynamic conditions.
[0026] In some embodiments, the microfluidic circuit includes a serial dilution module comprising branched channels of variable geometry that produce concentration gradients across the microwells to enable quantitative dose-response testing.
[0027] In some embodiments, all fluid movement and mixing is achieved through passive capillary action and channel geometry alone, with no external pumps or fiber or actuation elements.
[0028] In some embodiments, the top hydrophilic layer is reversibly bonded, allowing removal or access to the microwells after sample processing for the purposes of microscopy, reagent recovery, or downstream analysis.
[0029] In some embodiments, the sample inlet includes a fiber-based wick configured to interface with the skin surface and deliver eccrine sweat directly to the microfluidic circuit while minimizing bubble formation and maintaining continuous fluid connection.
[0030] In some embodiments, the microfluidic layout includes timing or delay channels configured to direct sequential fluid samples into separate microwells over time, enabling chrono-sampling for temporal biomarker monitoring.
[0031] In some embodiments, the apparatus is integrated into a wearable patch comprising a flexible substrate and optionally includes electronics or optics for data acquisition, signal processing, or wireless transmission.
[0032] In some embodiments, the apparatus is embedded within a swallowable capsule platform configured to sample gastrointestinal contents and segment luminal fluids into isolated droplets for downstream analysis.
[0033] In some embodiments, the microfluidic architecture is configured to minimize evaporation during incubation or thermal processing by sealing all fluid paths within laminated polymer layers and enclosing microwells between vapor-impermeable top and bottom films.
[0034] In some embodiments, the second end of each microwell connects to a passive venting channel through a hydrophobic valve structure that prevents evaporative loss while enabling pressure equalization during sample filling. The valve geometry and surface energy combination are configured to resist vapor transport while allowing capillary flow initiation.
[0035] In some embodiments, the capillary microfluidic circuit is modeled using an equivalent electrical circuit comprising resistive, capacitive, and pressure-driven analog elements. This analog modeling framework enables prediction of flow rates, valve opening delays, and filling sequences, and supports rapid optimization of microchannel geometry, surface properties, and fluid timing in response to variations in biological fluid type, viscosity, or assay requirements.
[0036] In some embodiments, the design, optimization, and troubleshooting of the microfluidic architecture are governed by an artificial intelligence (Al) framework trained on empirical flow data, physical simulations, and assay performance metrics. The Al system is configured to: (i) predict fluid dynamics and chip function; (ii) identify failure modes or design constraints; and (iii) autonomously generate new chip geometries optimized for specific droplet sizes, sample volumes, fluid types, orbiological workflows. The Al-guided process enables rapid adaptation of the microfluidic platform to new assay formats or performance targets.
[0037] In some embodiments, the microfluidic circuit is configured to execute multi-phase assays by sequentially delivering reagents, wash buffers, or detection probes into the microwells using geometry-based timing channels or capillary delay elements. This configuration enables on-chip multi-step protocols such as ELISA, nucleic acid amplification, or multiplex chemical reactions.
[0038] In some embodiments, the microwells are designed to encapsulate and culture single cells or cell clusters within individual droplets or hydrogel matrices, enabling high-throughput phenotyping, clonal expansion, or live-cell analysis directly within the microfluidic platform.
[0039] In some embodiments, each droplet or microwell is isolated and sealed post-sample loading using oil overlays, hydrophobic barriers, or adhesive membranes, thereby enabling long-term sample preservation, transport, or batch analysis without cross-contamination or degradation.
[0040] In some embodiments, inlet fluid is metered and divided across multiple microwells through precision-geometry branch channels or Al-optimized routing patterns, enabling uniform reagent distribution or programmable reagent dosing across multiple reaction zones.
[0041] In some embodiments, the sample inlet includes an integrated porous fiber element configured to wick and preprocess biological fluids such as whole blood. The fiber serves to initiate capillary flow, trap debris or red blood cells, and regulate flow rate prior to entry into the microfluidic circuit. The inlet design enables consistent operation with high-viscosity or particulate-containing samples without requiring centrifugation or dilution.
[0042] In some embodiments, a passive mixing region is positioned downstream of the sample inlets loaded with same phase liquid and upstream of the main flow channel. The mixing region comprises serpentine geometries, embedded micro-pillars, or split-and-recombine paths patterned within the adhesive layer(s), configured to induce chaotic advection or geometric dispersion to homogenize the fluid prior to droplet formation or compartmentalized routing.
[0043] In some embodiments, a passive mixing region is positioned downstream of the sample inlets and upstream of the main flow channel. The mixing region comprises serpentine geometries, embedded micro-pillars, or split-and-recombine paths patterned within the adhesive layer(s), configured to induce chaotic advection or geometric dispersion and ensure uniform mixing of fluid components. The integrated mixer eliminates the need for pre-mixed reagents, enabling on-chip combination of chemically or biologically sensitive components that exhibit reduced shelf-life when stored together prior to use.
[0044] In some embodiments, the microfluidic circuit comprises at least three fluid inlets: a first inlet for a biological sample, a second inlet for a target or challenge agent (e.g., bacteria or drug), and a third inlet configured to deliver an initiator fluid that synchronizes the timing and pressure-driven co-introduction of the first and second fluids. The initiator fluid enters a control channel or central junction, initiating simultaneous or sequential capillary flow from the other inlets into downstream reaction or mixing zones.
[0045] In some embodiments, the main flow channel is configured to function as a gradient-forming mixer, such that two or more fluids introduced via separate inlets are continuously mixed along the channel length through diffusion, channel geometry, or chaotic advection. The resulting spatial concentration gradient delivers distinct reagent compositions to different sets of microwells positioned along the main channel, enabling multiplexed assays such as dose-response analysis, MIC determination, or multiconcentration biochemical profiling.
[0046] In some embodiments, data generated from the microwells — such as optical, colorimetric, electrochemical, or fluorescence signals — is captured and analyzed using a smartphone camera, portable detector, or handheld reader. The device is configured to operate in field or resource-limited settings without laboratory infrastructure, enabling point-of-care diagnostics, decentralized monitoring, and realtime data transmission or cloud-based analysis.
[0047] In some embodiments, each microwell is configured with two inlet ports located at opposite ends, allowing simultaneous or sequential introduction of distinct fluids, reagents, or cell-laden hydrogels from independent flow paths. A centrally locatedair vent is formed through either the top or bottom layer to enable pressure-neutral displacement of air during filling without disrupting inlet flow balance. The entire operation is driven by capillary forces, without external pumps or actuation, and the configuration supports the high-throughput modeling of tissue-tissue interfaces such as epithelial-endothelial layers, tumor-immune compartments, or vascular-organ barriers. This structure enables parallel analysis of interaction dynamics across microwells under controlled, fully passive flow conditions.
[0048] In some embodiments, the microfluidic circuit includes a recirculating loop that enables reversible flow through microwells, allowing repeated exposure of cells or reagents and subsequent sample recovery. The loop is formed from capillary-controlled inlet and outlet arms connected via burst valves or retention zones, enabling timedependent interaction studies such as drug wash-in / wash-out, immune checkpoint modulation, or reversible cytokine stimulation without pumps.
[0049] In some embodiments, each microwell includes a self-isolating structure formed by capillary stop valves or rupture zones that isolate the well upon reaching a predefined volume or reaction threshold. The isolation is triggered by changes in surface tension, pressure, or chemical signal (e.g., oil overlay or reaction product), enabling autonomous compartmentalization of dynamic processes such as PCR amplification, pathogen growth, or on-chip titrations.
[0050] In some embodiments, one or more layers of the microfluidic circuit, including the main flow channel, are constructed from a semipermeable material configured to permit the selective passage of gases or small molecules while retaining liquids or larger biomolecules. The semipermeable structure supports applications requiring oxygenation, nutrient diffusion, or metabolite clearance, and enables physiological modeling of tissue barriers or controlled microenvironment exchange.
[0051] In some embodiments, adjacent microwells are separated by semipermeable membranes or hydrogel walls formed during chip fabrication or reagent loading. These walls allow molecular diffusion but restrict bulk flow, enabling paracrine signaling studies, chemotactic migration, or concentration-gradient response analysis between compartments.
[0052] In some embodiments, the sample inlet is geometrically configured to prevent vertical accumulation of fluid, such that the sample volume does not create a height-driven pressure head. The inlet structure ensures that fluid entry into the microfluidic circuit is governed exclusively by capillary forces, thereby eliminating gravity-dependent flow variation and improving reproducibility across user inputs, sample volumes, and chip orientations.
[0053] In some embodiments, the microwells are geometrically patterned in non-rectangular shapes, including circular, oval, trapezoidal, or asymmetric profiles, to optimize specific performance parameters such as droplet stability, filling efficiency, signal detection, cell morphology, or surface-to-volume ratio. The shape of each microwell is selected based on the intended biological or chemical application, and may be uniform across the chip or spatially varied to create functional zones.
[0054] In some embodiments, the microwells are circular or bowl-shaped to promote aggregation and spheroid formation of cells seeded within the wells. After formation, the top layer of the microfluidic device is configured to be peeled away, opened, or dissolved, enabling direct, intact retrieval of the formed spheroids for downstream applications such as transplantation, drug screening, or histological analysis. The design enables non-disruptive culture and harvest of 3D cellular structures within a high-throughput, capillary-operated platform.
[0055] In some embodiments, the apparatus is configured to operate on a tilting or rocking platform that enables bidirectional flow of culture media or biological fluids between designated inlet and outlet chambers. The induced oscillatory flow maintains nutrient exchange and applies physiological shear stress to cells cultured within the microwells, supporting long-term viability, mechanotransduction studies, and organ-on-chip modeling of dynamic tissue environments. The design requires no external pumps or valves and preserves full capillary compatibility.
[0056] In some embodiments, the microfluidic circuit includes a high-density array of 5,000 to 10,000 microwells, each configured to receive a nanoliter-scale droplet from a capillary-driven main channel. The main channel is engineered with calibrated hydrodynamic resistance and venting structures to sequentially and uniformly fill the microwell array without external pumps. The layout may comprise a single continuouschannel or multiple parallel channels, and enables high-throughput digital partitioning for assays such as digital PCR, single-cell analysis, or ultrasensitive biomarker detection.
[0057] In some embodiments, the microfluidic chip is configured to be mounted in a centrifuge and operated under low to moderate centrifugal force to enhance fluid loading into capillary-driven microwells. The centrifugal force assists in uniform sample distribution, bubble displacement, and complete filling of up to 50,000 microwells, while preserving the passive, pump-free operation of the device. This hybrid design improves droplet uniformity, throughput, and reproducibility in digital assays and high-volume biological workflows.
[0058] Another aspect of the present disclosure provides a method for collecting a biological sample, the method comprising: providing an apparatus according to any of the above aspects; delivering a biological fluid to the sample inlet, such that the biological fluid is separated into a plurality of individual droplets in the plurality of microwells.
[0059] In some embodiments, the method comprises separately collecting each of the plurality of individual droplets.
[0060] In some embodiments, the method comprises, after the biological fluid is separated into the plurality of individual droplets in the plurality of microwells, delivering an oil to microfluidic circuit such that the oil fills the main flow channel and isolates each individual droplet in one of the plurality of microwells.
[0061] Another aspect of the present disclosure provides a method of controlling the delivery of multiple fluid phases using an apparatus according to any of the above aspects, comprising the steps of introducing at least two distinct fluid phases through separate inlets and routing them through microfluidic pathways designed to control the timing and sequence of fluid entry into microwells.
[0062] In some embodiments, fluid movement is governed by capillary pressure gradients established by differences in channel geometry, surface energy, and valve configuration, eliminating the need for external flow drivers.
[0063] Another aspect of the present disclosure provides an apparatus for collecting sweat samples from a subject, comprising: a bottom layer and a top layer, each constructed from a hydrophilic material, and a plurality of adhesive layersdisposed between the bottom layer and the top layer, each adhesive layer constructed from a hydrophobic material, wherein: the top layer has an opening formed therein defining a sweat sample inlet; one of the plurality of adhesive layers defines a primary vent outlet; the plurality of adhesive layers have openings formed therein defining a microfluidic circuit comprising: an inlet chamber in fluid communication with the sample inlet; an outlet chamber in fluid communication with the primary vent outlet; a main flow channel connected between the inlet chamber and the outlet chamber; and a plurality of microchannels, each microchannel having a first end and a second end, the first end connected to the main flow channel, and the second end connected to the primary vent outlet through a capillary valve.
[0064] Further aspects of the present disclosure and details of example embodiments are set forth below.Drawings
[0065] The following figures set forth embodiments in which like reference numerals denote like parts. Embodiments are illustrated by way of example and not by way of limitation in the accompanying figures.
[0066] Figure 1 shows an example sample collection apparatus for separating a liquid sample into a plurality of individual droplets according to one embodiment of the present disclosure.
[0067] Figure 1 A is an exploded view of the apparatus of Figure 1 showing the individual layers thereof.
[0068] Figure 2 shows a portion of the main flow channel and microwell of an example sample collection apparatus having a pressure reducer and a stop valve connecting the second end of the microwell to a passive venting channel.
[0069] Figure 2A shows a portion of the main flow channel and microwell of another example sample collection apparatus having only a stop valve connecting the second end of the microwell to a passive venting channel.
[0070] Figure 2B is a graph illustrating the effect of a pressure reducer on microwell filling times.
[0071] Figure 3 schematically illustrates a comparison of drainage rates during evacuation of the main flow channel between a sample collection apparatus wherein each microwell has its own vent (Cap-Drop-N) and a sample collection apparatus with a passive venting channel network (Cap-Drop).
[0072] Figure 3A is a graph illustrating microwell drainage rates during evacuation of the main flow channel for a sample collection apparatus wherein each microwell has its own vent (Cap-Drop-N) and a sample collection apparatus with a passive venting channel network (Cap-Drop).
[0073] Figure 4 schematically illustrates the effect of a bubble trap on bubble velocity within a capillary channel.
[0074] Figure 4A is a graph comparing bubble velocity in a simple capillary channel to bubble velocity in a simple capillary channel with a bubble trap.
[0075] Figure 5 schematically illustrates a portion of a main flow channel with a width MF, a microwell with a width WM, and a stop valve with a width SV, of an example sample collection apparatus.
[0076] Figure 5A is a graph illustrating the effect of main flow channel width MF on both main flow channel loading time and volume.
[0077] Figure 5B is a graph showing normal distribution and uniformity of microwell volumes for a sample collection apparatus with different target volumes.
[0078] Figure 5C is a graph illustrating the effect of stop valve width SV on burst pressure for various biofluids.
[0079] Figure 6 shows an example sample collection apparatus specifically engineered for cell culturing within the microwells according to one embodiment of the present disclosure.
[0080] Figure 6A shows viability and proliferation of Caco-2 cells within the sample collection apparatus of Figure 6 encapsulated in Collagen I microgels and cultured for 24 hours.
[0081] Figure 6B shows viability and proliferation of Caco-2 cells within the sample collection apparatus of Figure 6 encapsulated in Collagen I microgels and cultured for 48 hours.
[0082] Figure 6C is a graph showing live / dead assay results for cell viability after 24 and 48 hours.
[0083] Figure 6D is a graph showing quantification of cell proliferation based on MKi67 expression analyzed through immunofluorescence imaging after 24 and 48 hours.
[0084] Figure 6E shows confocal microscopy and 3D reconstruction of the cultured cells.
[0085] Figure 7 schematically illustrates an example sample collection apparatus according to another embodiment of the present disclosure configured for chronosampling of sweat directly from human skin.
[0086] Figure 8 is an exploded view of an example embodiment of the sample collection apparatus of Figure 7, with enlarged views illustrating how the passive venting channels are sequentially closed as the microwells (CHs) are filled.
[0087] Figure 9 is an exploded view of another embodiment of the sample collection apparatus of Figure 7.
[0088] Figure 10 schematically illustrates three alternative configurations for forming a bridge channel between two sequential chambers of an example sample collection apparatus.
[0089] Figure 11 schematically illustrates (i) conventional venting of microwells; (ii) parallel passive venting of microwells; and (iii) series passive venting of microwells, along with equivalent electrical circuits (EECs).
[0090] Figure 12 shows an example in vitro comparison of stop-valve access to the primary vent outlet (PVO) at the downstream end of each microwell with series (left image) and parallel (right image) venting configurations, with liquid introduced using a syringe pump at a flow rate of 18 pL / min.
[0091] Figure 12A is a graph showing stop-valve access to the PVO at the downstream end of each microwell with series and parallel venting configurations.
[0092] Figure 13 is a series of photographs illustrating on-body application of an example Cap-Sweat apparatus in human volunteers showing six sequential sampling zones (scale bar: 2 cm).
[0093] Figure 13A is a graph showing in vitro validation of temporal fidelity, where alternating purple and yellow dyes were injected through the inlet, producing a color gradient across CHs and demonstrating continuous tracking capability of biomarker fluctuations.
[0094] Figure 13B is a graph showing time-resolved cortisol concentration profiles from three subjects (Sb1, Sb2, Sb3), determined via ELISA from sweat collected across six zones.
[0095] Figure 13C is a graph showing corresponding sweat excretion rates measured across six zones from three subjects, enabling high-resolution quantification of dynamic sweat secretion kinetics.Detailed Description
[0096] The present disclosure provides novel preprogrammed, capillary-driven droplet microfluidic systems, which eliminate the need for external pumps or intricate control mechanisms. Through strategic integration of hydrophilic and hydrophobic materials with innovative capillary elements — such as passive vents, stop valves, pressure reducers, delay channels, and bubble traps — microfluidic apparatus, systems and methods according to the present disclosure (which may be referred to by the trademark “Cap-Drop™”) enable robust, precise, and bubble-free droplet generation (with droplet sized ranging from about 40-500 nL) for biofluids with diverse properties. The systems have a pre-programmed passive vent that autonomously seals microwells during sample progression, ensuring consistent sample digitization and minimizing evaporation risks, as discussed further below.
[0097] Cap-Drop microfluidic platforms may enable reliable, selfpowered generation and positioning of droplets in a throughput, simple, user-friendly design, eliminating the need for any external actuators. Unlike conventional droplet microfluidic systems, which face challenges in tracking and identifying moving droplets, Cap-Drop systems provide fixed droplet positioning, enabling unambiguous tracking and effortless analysis. This versatile system demonstrates broad applicability, from throughput 3D cell culture models for advanced drug testing to the digitization of various biofluids with different mechanical properties. It accommodates a wide range of biofluids, includingsweat, blood, and saliva, showcasing its adaptability for diverse biomedical and diagnostic applications. Droplet arrays are generated upon introducing the sample solution to the Cap-Drop inlet, benefiting from a fast-loading time compared to previous vacuum and capillary based systems.
[0098] Cap-Drop systems ensure reliable, bubble-free droplet generation with no evaporation or contamination, thanks to strategically integrated capillary elements including passive vents (PV), stop valves (SV), pressure reducers (PR), delay channels, and bubble trap(BT). The flexible, transparent, and biocompatible design offers a robust, scalable solution for droplet array generation using low-cost materials. As a proof of concept, an example prototype Cap-Drop apparatus produced a throughput array of >100 droplets, each containing an intestinal cell-laden microgel spheroid confined to its own microwell (MW), these droplets were cross-linked in situ, and cultured on-chip for 48 h, allowing real-time monitoring of cell viability and functionality. Compared to commercial high-throughput platforms for spheroid and organoid generation — such as AggreWell microwells, Coming ULA plates, InSphero hanging drop systems, and CELLINK droplet bioprinting setups — Cap-Drop systems offer a simpler and more accessible alternative. Those conventional systems often depend on robotic pipetting, external actuators, or bioprinters for droplet placement and cell handling. In contrast, Cap-Drop systems use a fully passive, self-powered mechanism to autonomously generate, position, and isolate droplets, eliminating the need for external equipment. This enables rapid prototyping and parallel culture of 3D cell constructs in a compact, low-cost format. Its transparency, modularity, and on-chip compatibility with imaging and analysis makes it especially well-suited for early-phase drug screening and mechanistic assays.
[0099] As discussed below and detailed in “Cap-Drop: A Pre-Programmed, Self-Powered Capillary Microfluidic System for Passive Droplet Generation and 3D Cell Culture Modeling”, Jalali et al., Small, 2025, 21, 2411997, and “Cap-Sweat: a capillary microfluidic platform for digitized sweat sampling and time-resolved biomarker analysis”, Jalali et al., Lab Chip, 2026, 26, 2734-2746, both of which are hereby incorporated by reference herein, the versatility of Cap-Drop apparatus and systems have been validated across multiple applications. For 3D cell culture, the Cap-Drop-Cell variantfacilitated the formation of uniform, cell-laden microgels, enabling real-time monitoring of intestinal cell spheroids over 48 hours. This biocompatible, scalable design highlights its potential for advanced 3D culture models. For sweat collection, the Cap-Drop-Sweat (or simply “Cap-Drop) enables chrono-sampling by providing for sequential collection of sweat droplets and prevents evaporation of collected droplets. Unlike conventional droplet systems, Cap-Drop systems offer fixed droplet positioning, enabling unambiguous tracking and analysis, while the user-friendly, passive design ensures accessibility and affordability.
[0100] The findings disclosed herein demonstrate that Cap-Drop systems are not only a competitive alternative to conventional droplet microfluidics and bioprinting but also a transformative platform for applications spanning drug testing, precision diagnostics, and wearable biosensors. The systems’ throughput capabilities, biocompatibility, and adaptability to diverse biofluids — including sweat, blood, and saliva — underscore its potential to advance preclinical, clinical, and point-of-care applications.
[0101] For simplicity and clarity of illustration, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.Numerous details are set forth to provide an understanding of the examples described herein. The examples may be practiced without these details. In other instances, well-known methods, procedures, and components are not described in detail to avoid obscuring the examples described. The description is not to be considered as limited to the scope of the examples described herein.
[0102] Figures 1 and 1A show an example sample collection apparatus 100 according to one embodiment of the present disclosure. In the illustrated example, apparatus 100 is constructed from five layers - a bottom layer 102, three intermediate adhesive layers, namely a first adhesive layer 104-1, a second adhesive layer 104-2, a third adhesive layer 104-3, and a top layer 106. Other embodiments may have different numbers of layers by providing additional or fewer intermediate adhesive layers. The bottom layer 102 and top layer 106 are made from hydrophilic polyethylene terephthalate (PET), providing the capillary force needed to drive the sample solution through the main flow channel 113 (MF) and microwells 115 (MWs) as described below.The bottom layer 102 is pattern-free and simply provides capillary force. The top layer 106 includes openings for an inlet 108 and a vent 110, which are the only points exposed to open air for sample injection and air exit during the loading phase.Adhesive layers 104-1 , 104-2 and 104-3 are patterned (e.g. using a CO2 laser or other means for patterning the layers) to define a microfluidic circuit comprising an inlet chamber 112 connected to an outlet chamber 114 by a main flow channel 113, with a plurality of microwells 115 each having a first end connected to the main flow channel 113 and a second end connected to a passive venting channel 120. A wicking pad 109 is disposed within the outlet chamber 114 as described further below. The passive venting channels 120 are connected to a downstream portion of the main flow channel 113 between a last one of the microwells 115 and the outlet chamber 114 to provide fluid communication between the second ends of the microwells 115 and the vent 110. In the illustrated example, the main flow channel 113 comprises a flow control element in the form of a delay channel 116 downstream of the last of the microwells 115, and a bubble trap 117 downstream of the delay channel 116, with the passive venting channels 120 connected to the main flow channel 113 downstream of the bubble trap 117. In other embodiments, the passive venting channels 120 may be connected to the main flow channel 113 at other locations between the last one of the microwells 115 and the outlet chamber 114. In the illustrated example, the second end of each microwell 115 is connected to a passive venting channel 120 (PV) through a stop valve 119 (SV), and the second end of each microwell 115 also comprises a pressure reducer (PR) as described below.
[0103] Adhesive layers 104-1, 104-2 and 104-3 are hydrophobic, double-sided adhesives with different patterns, but all share the inlet chamber 112, main flow channel 113, outlet chamber 114 and microwells 115. The central adhesive layer 104-2 has an additional pattern to form the stop valves 119 and passive venting channels 120 and is sandwiched between adhesive layers 104-1 and 104-3. As a result, these elements are isolated from the top and bottom layers 102 and 106, making them fully hydrophobic and preventing the sample solution from entering the passive venting channel network. The length of the microwells 115 is the same in both adhesive layers 104-1 and 104-2, (L1 =L2), but it is shorter in adhesive layer 104-3 to create a small step called apressure reducer PR (L3 < L2), which locally reduces capillary pressure before each stop valves 119. This helps improve SV stability and minimizes the risk of failure during sample loading. Figures 2 and 2A respectively show an example of a microwell connected to a stop valve with and without a pressure reducer, and Figure 2C is a graph illustrating the effect of a pressure reducer on microwell filling times.
[0104] To ensure ease of fabrication, in some embodiments, the patterning of layers starts with adhesive layer 104-1, followed by adhesive layers 104-2 and 104-3, and then the top layer 106. Once the patterning of adhesive layer 104-1 is complete, the next adhesive layer 104-2 is immediately attached over it. The CO2 laser (or other patterning means) then proceeds to pattern adhesive layer 104-2, and the process continues sequentially to apply and pattern adhesive layer 104-3. The wicking pad 109 (Wp) is inserted into the outlet chamber 114 prior to application and patterning of the top layer 106, providing a secondary capillary source needed to remove excess sample from the main flow channel 113. With this innovative fabrication process, by the time the laser finishes patterning all the layers, they are already pre-aligned and bonded together, removing the need for any alignment.
[0105] Sample collection apparatus 100 leverages capillary forces to autonomously manipulate fluids and to generate and position discrete droplets within the microwells 115. Once a sample solution is introduced to inlet 108, it moves through the main flow channel 113 and into the microwells 115, driven by the capillary forces generated by the hydrophilic layers. As the sample enters the microwells 115, air is vented out through the passive venting channels 120, which remain open during the loading phase. Once all microwells 115 are filled and the sample solution reaches the wicking pad 109, the loading phase is complete, and the passive venting channels 120 automatically close, trapping the sample within the main flow channel 113 and securing droplets in each microwell 115. Following this, the main flow channel 113 is evacuated via the capillary force provided by wicking pad 109, digitizing sample solution within the microwells 115.
[0106] During initial testing of a prototype embodiment, some crosstalk between MWs was observed, where fluorescent nanoparticles were seen migrating between adjacent MWs through a thin residual aqueous film remaining on the MF walls aftersample evacuation. The presence of these unintended fluid connections disrupts one goal of systems according to certain embodiments, of the present disclosure of generating discrete droplets that can serve as separate reaction chambers for various applications. To address this issue, in some embodiments an immiscible oil phase is introduced to the inlet 108, filling the main flow channel 113 and forcing air out through the vent 110. This step eliminates crosstalk and significantly reduces evaporation of the aqueous samples within microwells 115 as they are sealed from ambient air. The oil moves through the main flow channel 113 via capillary force, facilitated by the vertical walls of the main flow channel 113 made from oil-friendly, non-polar material that forms a low contact angle with the oil. To enhance oil’s flow rate through the main flow channel 113, in some embodiments a critical micelle concentration of Span 20 is added to lower the oil’s contact angle with the surfaces of the main flow channel 113, further enhancing capillary forces and accelerating oil movement.
[0107] Variations in viscosity, concentration, size, and mass between cells and microparticles lead to distinct flow behaviors within microwells 115. In some embodiments, the sample collection apparatus 100 is optimized for these flow properties for each target sample making it a versatile microfluidic system.
[0108] The sample collection apparatus 100 employs a variety of innovative capillary elements, compatible with the laser cutting fabrication process, to streamline and enhance the three phases for sample digitization of methods according to certain embodiments of the present disclosure: loading the MF and MWs with sample solution, evacuating the MF, and filling the MF with oil. Successful MF and MW loading requires three key factors: providing adequate capillary force to drive the sample into the MF and MWs, creating an air exit at the end of each MW to ensure bubble-free filling, and stopping the flow at the end of MWs before it reaches PV. In some embodiments, the capillary force is generated by the hydrophilic PET used in the top and bottom layers, satisfying the first requirement, the PVs address the second need by providing a pathway for air to exit, and the SVs fulfill the third requirement by halting the sample flow at the end of the MWs, preventing it from entering the PVs. Without reliable SVs, the sample would fill the PVs, leading to failed digitization even after MF evacuation, asMWs would remain interconnected through the PVs. Thus, the performance of the PVs in Cap-Drop is tightly linked to the effectiveness of the SVs in some embodiments.
[0109] The PV network within a Cap-Drop sample collection apparatus is an important design feature, connecting all MWs and providing a safe pathway for air to escape during MW loading. Its importance is highlighted when compared to a simpler alternative, Cap-Drop-N, which uses normal vents (Norm-Vs) in place of the PV network, as shown in Figure 3. In Cap-Drop-N, each MW is equipped with a small hole (Norm-V) that allows air to escape. While this design simplifies construction by requiring only one adhesive layer and eliminates the need for PV and SVs, it introduces significant risks of evaporation and contamination. These issues are particularly critical for the small liquid volumes handled in MWs (40 to 500 nL), where even minor evaporation is typically unacceptable. Although Cap-Drop-N meets the criteria for successful loading of MF and MWs, it fails during MF evacuation — as illustrated in Figure 3A. For successful MF evacuation, the sample solution must reach the Wp, where its capillary force effectively evacuates the MF without draining MWs. In Cap-Drop-N, a positive capillary pressure is generated by the Wp, while a negative pressure arises due to the receding contact angle caused by the hydrophilic layers during MF draining. Furthermore, the Norm-V introduces air access to each MW, generating reverse pressure at the end of each MW. This reverse pressure is determined using the Yang-Laplace equation. Analysis for Cap-Drop-N revealed high drainage rates (Id9 and Id10) in MW9 and MW10 (Figure 3A), confirmed by COMSOL Multiphysics simulations and real experiments. As a result, air entered the Wp through the Norm-Vs in MW9 and MW10, disconnecting the Wp from the sample solution in the MF and leading to failed MF evacuation.
[0110] Accordingly, in sample collection apparatus according to preferred embodiment of the present disclosure PVs must remain open during the loading phase to allow air to escape from the chip, and must then close automatically as the apparatus transitions from the loading phase to the MF evacuation phase. Closing the vents during the evacuation phase prevents air from re-entering MWs, ensuring that drainage occurs only through the MF and not MWs. This important function is enabled by the PV design, in conjunction with the Wiki-V located at the end of the Wp. The PV consists of anetwork of channels connecting all MWs, with its last branch linked to the MF, providing access to the Wiki-V when it is not filled with sample solution. The PV remains open as long as it maintains access to the Wiki-V and closes automatically once the sample solution reaches the last branch of the PV. A delay channel placed before the PV’s last branch ensures sufficient time for all MWs to fill before the PV closes. The successful incorporation of the PV and SVs not only meets all the criteria for successful loading and evacuation in Cap-Drop systems, but also eliminates risks of evaporation and contamination. This improvement stems from replacing all Norm-Vs at the end of MWs in Cap-Drop-N with the PV, which works in conjunction with the Wiki-V to enhance Cap-Drop’s enclosed design. In the final step of the Cap-Drop workflow, an immiscible oil phase is introduced to completely fill the MF under capillary flow, ensuring full encapsulation and digitization of droplets within MWs.
[0111] During the evacuation phase of the MF, air bubbles may potentially enter the system. This typically occurs through the inlet, especially as it starts draining. The likelihood of this depends on the sample’s adhesion to the inlet surface and its physical properties. Air bubbles may also from via small gaps between adhesive layers caused by misalignment or minor fabrication issues. If a bubble forms, it may travel toward the end of the MF and create a gap between the Wp and the remaining sample solution, ultimately leading to unsuccessful evacuation. To mitigate this risk, the sample collection apparatus 100 includes a bubble trap 117 (BT) positioned before the Wp. The BT operates based on Newton’s second law, reducing the bubble’s velocity to zero at its trapped position, thereby preventing it from reaching the Wp. This is achieved by designing the BT with a wider width compared to the MF, which reduces the flow rate and decreases the drag force acting on the bubble. Furthermore, in some embodiments the BT has a pentagonal shape which induces a flow pattern around the bubble, stabilizing it in an equilibrium position. Surface tension between the bubble and the MF walls also plays a critical role in the BT’s functionality, further immobilizing the bubble at the trap location, as illustrated in Figures 4 and 4A. It is noted that the BT has a finite capacity and may become saturated if the bubble volume exceeds its holding capacity. In such cases, the bubble could escape the trap and reach the Wp, potentially resulting in the failure of the system. For example, when an air bubble introduced through Norm-V in Cap-Drop-N exceeded the capacity of the BT, the chip was unable to complete the evacuation phase.
[0112] Figure 5 schematically illustrates a portion of a main flow channel with a width MF, a microwell with a width MW, and a stop valve with a width SV, of an example sample collection apparatus. The MF dimensions play an important role in influencing capillary pressure, hydraulic resistance, and overall fluid flow within the \system. Using the Hagen-Poiseuille equation, the flow rate is calculated based on both capillary pressure and hydraulic resistance. The pressure in the MF, with its rectangular cross section, varies depending on the contact angles of the channel walls and is determined using the Young-Laplace equation. The resistance is dynamic and evolves as the fluid interface progresses through the MF, reflecting changes in flow conditions. To model the flow rate within the MF as the fluid interface advances, the MF is divided into small segments, each with nearly constant resistance. The flow rate for each segment is calculated using the Hagen-Poiseuille equation based on the interface’s position. The capillary flow rate decreases as the channel fills, which is evident from the tracing of the air-liquid interface. This decrease occurs because, while the pressure remains constant, the resistance increases with the volume of fluid in the MF, leading to a progressively lower flow rate. To optimize the MF width, experiments were performed using a 20 cm MF with varying widths, tracking the loading time for each biofluid. Narrower channels increase resistance but reduce pressure due to the hydrophobic nature of the vertical walls. As shown in Figure 5A, the optimal width was identified by balancing loading time with the volume of sample retained in the MF, achieving an efficient compromise between these parameters for optimal performance.
[0113] The uniformity of digitized sample volumes across more than 100 MWs in the Cap-Drop sample collection apparatus is highly dependent on MW width. To investigate its impact on volume uniformity, a variant called Cap-Drop-w was developed, where MWs width gradually increases along the MF, with each width repeated four times. This configuration was tested using two biofluids with differing viscosities: water and blood, representing low- and high-viscosity fluids, respectively. The effect of MWs width on the uniformity of digitized samples becomes evident during the MF evacuation phase when the MF and a portion of each MW are drained, forming a meniscus at theemptied MW. The inventors have determined that increasing the MW width leads to larger error bars in the emptied section, which compromises the uniformity of digitized sample volumes across MWs. Additionally, for MWs widths greater than 1 mm, bubble form at the end of the MW due to the corner flow effect, disrupting bubble-free operation. Recognizing the need for uniformity and a bubble-free environment, MW width should be no more than about 0.9mm and preferably between about 0.5. mm and about 0.7mm. The precision of MW fabrication using a CO2 laser cutter also affects sample volume uniformity, in addition to the variation in emptied wells. By maintaining the MWs width between 0.5 and 0.7mm within the optimized zone and varying other dimensions like the height and length of MWs, three different prototype apparatus were developed, which successfully digitized sample to droplets with volumes of 40, 170, and 300 nL, achieving coefficients of variation (CV) of 6.31%, 6.71%, and 7.5%, respectively, as shown in Figure 5B. This demonstrates the system’s versatility and flexibility in performance.
[0114] A simple rectangular channel was implemented as the SV to streamline the fabrication process of Cap-Drop. Figure 5C shows the calculated burst pressure of the SV, derived from the Young-Laplace equation, which factors in the width, height, and contact angle between the SV walls and the biofluid. While the height of the SV is constrained by the thickness of adhesive layer 104-2 in the example apparatus of Figure 1, the contact angle is determined by the biofluid’s properties. Consequently, the SV width becomes the sole adjustable parameter for optimization. As shown in Figure 5C, reducing the SV width increases the burst pressure, enhancing the SV’s durability. However, the minimum achievable width in currently practical embodiments is limited to 120 pm due to the precision constraints of the laser cutting process. Results indicate that the Cap-Drop system performs effectively with biofluids such as blood, plasma, saliva, and water. However, the findings also highlight the advantage of incorporating a PR to mitigate potential SV failure under lower pressures, particularly when working with low-viscosity fluids like water.
[0115] Notably, regardless of the SV width, the system struggled to prevent sweat from entering the PV. The present disclosure also provides other embodiments of sample collection apparatus configured for collection of sweat and fluids with similarproperties, referred to as the “Cap-Sweat” system and described further below with reference to Figures 7-13.
[0116] As noted above, although the Figure 1 embodiment the sample collection apparatus 100 comprises five layers with hydrophobic top and bottom sheets, other embodiments may provide a sample collection apparatus with a different number and / or configuration of layers. The use of hydrophilic sheets on both the top and bottom layers in the sample collection apparatus 100 of Figure 1 generates strong capillary forces, enabling rapid sample loading. However, this design poses challenges for applications requiring precise and independent liquid deposition, such as delivering varying drug concentrations or nutrients into each MW via drop casting. In these scenarios, the hydrophilic surface causes the liquid to spread from one MW into the MF and adjacent MWs. To overcome this limitation, in some embodiments, the top hydrophilic layer may be replaced with a hydrophobic adhesive. This modification prevents spreading and allows accurate drop-casting directly into individual MWs. Drop-casting of drugs or stimuli with varying concentrations is performed before sealing the chip, by dispensing droplets into each MW and allowing them to evaporate, leaving behind solid drug deposits. Once this step is completed, the bottom (hydrophilic) layer is attached, forming a fully enclosed microfluidic system. Upon sample introduction, the dried contents rehydrate, creating distinct local environments across the MW array. For scalable production, this workflow can be adapted to automated pipetting platforms. The hydrophobic top layer increases the loading time for biofluids compared to the example of Figure 1. Additionally, it eliminates the need for a third adhesive layer, which previously acted as a barrier between the SV and the hydrophilic top layer. This reduces the MW height by 0.33% and decreases the sample volumes. The slower sample movement reduces the pressure on the SV, making the PR unnecessary. Accordingly, sample collection apparatus according to some embodiments of the present disclosure provide a four-layer configuration while maintaining reliable performance.
[0117] Figure 6 shows an example sample collection apparatus 100A, which may be referred to as a “Cap-Drop-Cell” system, specifically engineered for cell culturing within the microwells according to one embodiment of the present disclosure. The sample collection apparatus 100A of Figure 6 is specifically engineered for cell culturingwithin MWs, in a 3D format (Figure 6E) with acceptable cell coverage across each MW over 48 h (Figures 6A and 6B). Figure 6A shows viability and proliferation of Caco-2 cells within the sample collection apparatus of Figure 6 encapsulated in Collagen I microgels and cultured for 24 hours. Figure 6B shows viability and proliferation of Caco-2 cells within the sample collection apparatus of Figure 6 encapsulated in Collagen I microgels and cultured for 48 hours. Figure 6C is a graph showing live / dead assay results for cell viability after 24 and 48 hours. Figure 6D is a graph showing quantification of cell proliferation based on MKi67 expression analyzed through immunofluorescence imaging after 24 and 48 hours. Figure 6E shows confocal microscopy and 3D reconstruction of the cultured cells.
[0118] The Cap-Drop-Cell design is fully compatible with cell tracking, live imaging, growth pattern analysis, and immunostaining, making it suitable for applications such as biocompatibility assessment, cell-cell and cell-matrix interaction studies, gene expression analysis, and drug testing. In some embodiments of sample collection apparatus 100A of Figure 6, the MF evacuation is simplified using standard suction equipment commonly available in cell culture laboratories, eliminating the need for the Wp. Additionally, the design incorporates dual reservoirs to supply culture media during incubation. A chip rocker facilitates continuous media flow through the MF, ensuring adequate aeration and nutrient delivery to MWs while efficiently removing waste materials. This setup supports optimal cell viability and enables extended culture periods, providing a versatile and user-friendly platform for cell-based assays.
[0119] In the Cap-Drop microfluidic device, individual 3D cultures can be accessed using enzymatic (e.g., collagenase or trypsin) or mechanical methods for downstream analysis such as flow cytometry, RT-qPCR, or single-cell sequencing. As the Cap-Drop device operates using capillary flow and does not require external pressure, we utilize pressure-sensitive adhesive (PSA) to bond the top layer to the rest of the chip in a semi-permanent manner. This allows the top layer to be securely attached during culture while enabling easy removal post-fixation by applying minimal pressure during assembly. Peeling off the top layer grants access to all MWs and fixed reagents without disrupting the underlying structures, thus facilitating gentle and spatially resolved sample retrieval for post-experimental analysis.
[0120] The results from the LIVE / DEAD assay indicated negligible cell viability in the Cap-Drop-Cell chips made with the material ARcare@93049, which was identified as toxic. In contrast, cells cultured in chips made from the bioinert material 3M-9984 remained fully viable after 24 and 48 h of culture with showing 99.02% and 98.96% of live cells. Immunostaining for MKi67 revealed that 79.04% of cells were positive after 24 h of culture, and 69.89% were positive after 48 h, indicating robust cell proliferation. Cap-Drop-Cell microenvironment demonstrated excellent biocompatibility, supporting cell proliferation and viability within 3D Collagen I microgels for up to 48 h of incubation. This duration provides sufficient time for conducting most species reaction modeling and other related analyses.
[0121] In addition to collagen-based hydrogels, the Cap-Drop-Cell is compatible with other biologically relevant materials such as Matrigel, fibrin, gelatin methacryloyl (GelMA), and alginate, which offer appropriate rheological properties for stable loading and confinement within MWs. For example, 5 wt.% GelMA — an increasingly common material in 3D cell culture — was successfully loaded into a Cap-Drop system, demonstrating reliable performance at viscosities as high as«300mPa s. This represents a substantial increase over typical biofluids and highlights the platform’s capacity to accommodate moderately viscous hydrogels used in advanced cell culture applications. Highly viscous, non-shear-thinning hydrogels may hinder performance due to flow resistance or swelling, which captures the trade-off between viscosity and capillary flow rate. Materials like polyacrylamide (PAM) and poly(2-hydroxyethyl methacrylate) (PHEMA), and unmodified hyaluronic acid (HA) exemplify such limitations.
[0122] To evaluate system performance under extended incubation, Cap-Drop-Cell chips were maintained at 37 °C in a humidified incubator for four days. Following 24 h of exposure, the media loading time increased from 15 to 48 s, likely due to the combined effects of elevated temperature and humidity. From day 2 to day 4, loading times increased more gradually to 55, 65, and 71 s, respectively, indicating consistent capillary performance over the full culture duration.
[0123] Figure 7 schematically illustrates an example sample collection apparatus 200, which may be referred to as “Cap-Drop-Sweat” or simply “Cap-Sweat”, accordingto another embodiment of the present disclosure configured for chrono-sampling of sweat directly from human skin. In the illustrated example, the Cap-Drop-Sweat chip is in the form of a wearable patch and comprises of six sequential zones of microwells, also referred to as microchambers (CH), designed for sweat collection over time. An exploded view of the example sample collection apparatus 200 of Figure 7 is shown in Figure 8.
[0124] While the Cap-Sweat system retains the core capillary architecture and droplet immobilization principles of the Cap-Drop system, it introduces important modifications to its capillary circuit (CC) to accommodate sweat flow, enhance skin compatibility, support flexible substrates, and improve evaporation resistance. The Cap-Sweat system comprises sequential CHs interconnected through a programmable CC that enables autonomous fluid handling. This provides a wearable microfluidic system that enables pressure-independent, ventless chrono-sampling with deterministic sequential compartmentalization under physiological conditions. Sequential filling is governed by an engineered hierarchy of capillary forces and hydraulic resistances that directs fluid progression from one CH to the next independent of sweat secretion rate. Rather than relying on glandular pressure, hydrophobic capillary burst valves, or active flow control, the intrinsically hydrophilic CH and MF surfaces enable spontaneous fluid uptake and capillary-driven transport, minimizing sweat accumulation at the inlet and ensuring robust operation across physiological conditions. This geometry-programmed capillary mechanism discretizes continuously generated sweat into sequential constantvolume samples, preserving temporal sample integrity and preventing mixing between successive fractions. By using non-breathable laminates and eliminating vent-related evaporation losses, the Cap-Sweat system preserves chrono-resolved sweat samples in discrete CHs for offline biochemical analysis. During exercise studies, the system demonstrated its capability to quantify sweat rate dynamics and monitor temporal cortisol variations, highlighting its potential as a foundational platform for wearable bioanalysis, physiological monitoring, and biomarker discovery in health, fitness, and clinical applications.
[0125] With reference to Figures 7 and 8, sample collection apparatus 200 comprises six layers: a bottom layer 202 (which is the farthest from the subject’s skin),three spacer layers 204-1 , 204-2 and 204-3, a top layer 206, and a skin adhesive layer 207, with the top and bottom layers 206 and 202 of the microchannel made from hydrophilic material. An inlet wicking fiber 209 is disposed within an inlet chamber 212 defined in all layers except the bottom layer. A primary vent outlet 210 (PVO) is defined in the central spacer layer 204-2, and is in fluid communication with outlet chamber 214 formed in all three spacer layers 204-1 , 204-2 and 204-3. A main flow channel 213 (MF) is connected between the inlet chamber 212 and the outlet chamber 214, and has a plurality of sequentially arranged microchannels 215 (CHs) extending therefrom. The microchannels 215 are arranged in groups of three, with the second end of each microchannel 215 connected to the second end of the subsequent microchannel 215 in the group by a stop valve 219 (SV), and the second end of the last microchannel 215 in a group connected to the first microchannel 215 in the next group (or to the outlet chamber 214 in the case of the last group) by a passive venting channel 220.
[0126] All layers of a prototype embodiment of the sample collection apparatus 200 of Figure 8 were designed using AutoCAD and fabricated through a sequential layer-by-layer process using a CO2 laser cutter (Trotec Speedy 360 FLEXX, 80 W CO2 and 30 W fiber laser). This approach enabled precise patterning and bonding of each spacer layer before processing the next, allowing the laser to cut through already aligned, bonded layers without requiring manual realignment — akin to additive manufacturing. The multilayer laminated structure included top and bottom sealing layers. To modulate the capillary driving force, one or both sealing layers were fabricated from hydrophilic PET. The intermediate spacer layers, made of hydrophobic PSA, were patterned to form the customized MF, CHs, SVs, and air conduits. Laser parameters were optimized to power 80%, speed 70%, frequency 5000 Hz, and two passes to ensure smooth channels without residue. A laser-cut wicking fiber 209 (SterliTech CFP42-457) was embedded at the inlet to draw sweat from the skin into the MF. The sample collection apparatus 200 incorporates six sequentially filling zones (each containing three consecutive CHs), together with a central MF, centralized venting network, SVs, and pressure-reduction steps to enable controlled, evaporation-free chrono-sampling. No external power sources, pumps, or burst valves are required.
[0127] Figure 9 shows another example sample collection apparatus 200A according to another embodiment of the present disclosure configured for chronosampling of sweat directly from human skin, which comprises four layers: a bottom layer 202, two spacer layers 204-1 and 204-2, and a top layer 206A which also functions as a skin adhesive layer, where the top layer 206A is hydrophobic and the bottom layer 202 is hydrophilic.
[0128] Both sample collection apparatus 200 of Figure 8 and the sample collection apparatus 200A of Figure 9 demonstrated acceptable performance in collection of sweat, and one or the other may be preferred depending on the intended application. The six-layer version shown in Figure 8 provides a larger volume per microwell and stronger capillary force because both the top and bottom layers are made of hydrophilic material. In contrast, the four-layer version shown in Figure 9 uses fewer layers and is simpler to fabricate; however, only the bottom layer is hydrophilic, resulting in lower capillary force. The four-layer version may be preferred when drug solutions, detection reagents, or other materials need to be drop-cast into each microwell, because the hydrophobic surface can help retain the deposited droplets during preparation. In both formats, the hydrophobic spacer layers are constructed using medical-grade, double-sided PSA films, which simultaneously serve as bonding agents and structural elements. These PSA spacer layers provide conformal adhesion across interfaces, maintaining fluidic integrity even under repetitive skin deformation encountered during motion or physical exertion. The modular nature of the Cap-Sweat assembly enables functional partitioning across layers and supports integration of diverse materials to tune capillary resistance, channel geometry, and surface energy — allowing precise control of flow behavior without requiring capillary burst valves, active pumping, or mechanical actuation.
[0129] Capillary pressure in the Cap-Sweat system is controlled by tuning the surface wettability of the microchannel boundaries. In the configuration of sample collection apparatus 200 of Figure 8, both the upper and lower sealing layers are hydrophilic, which promotes uniform capillary action and spontaneous fluid propagation throughout the microfluidic network. In contrast, the configuration of sample collection apparatus 200A of Figure 9 employs an asymmetric design consisting of a hydrophobictop surface and a hydrophilic base layer. Both configurations enable reliable capillary-driven transport across physiologically relevant sweat-rate conditions. However, sample collection apparatus 200 of Figure 8 requires additional SP layers, resulting in a thicker and mechanically stiffer multilayer structure. By contrast, sample collection apparatus 200A of Figure 9 achieves reliable fluid transport with fewer layers, leading to reduced device thickness, improved mechanical flexibility for conformal skin contact, and greater robustness to CO2-laser fabrication variability, while maintaining sufficient capillary driving force independent of sweat-gland pressure. Additionally, the hydrophobic surface in sample collection apparatus 200A of Figure 9 enables pre-functionalization of CHs through drop-casting of dry reagents prior to final lamination. This asymmetric wettability preserves robust capillary transport while enabling reagent preloading, thereby expanding the platform's capability for integrated sensing and biochemical analysis.
[0130] As shown in Figure 7, the Cap-Sweat device initiates fluidic operation via a single inlet positioned directly above an eccrine sweat gland. A laser-patterned porous fiber element is integrated at the inlet site to form a continuous capillary interface between the epidermis and the device, thereby establishing a low-resistance fluidic pathway for passive sweat uptake. This fiber acts as both a wicking element and a flow stabilizer, ensuring consistent fluid transfer under low secretion rates and during dynamic skin movement. Upon entry, sweat is transported into the MF that traverses the length of the device and interfaces with a series of discrete CHs.
[0131] In both sample collection apparatus 200 and sample collection apparatus 200A, the microfluidic circuit incorporates 18 CHs. In sample collection apparatus 200 with six layers this provides a maximum operational volume of -99-103 pL, while sampling begins once the first CH is filled at approximately -18 pL. The number and geometry of the CHs are readily adaptable to accommodate diverse application needs, including enhanced temporal granularity or increased sample volume for low-abundance biomarker analysis. In addition, the inlet geometry can be adjusted to regulate sweat intake, enabling extended sampling durations.
[0132] To prevent uncontrolled lateral spreading despite the use of hydrophilic sealing layers, the microfluidic circuit in both sample collection apparatus 200 andsample collection apparatus 200A incorporates an engineered capillary pressure hierarchy and hydraulic resistance contrast that direct fluid into the collection CHs. The CHs are designed with a lower capillary entry barrier and reduced flow resistance relative to the adjacent MF, making CH filling energetically more favorable than lateral propagation along the MF. This design ensures bubble-free flow, enabling deterministic fluid localization within the CHs, and preventing cross-contamination between sequential compartments. Accordingly, this design preserves the chronology of sweat secretion for downstream biomarker analysis.
[0133] To facilitate continuous air displacement and mitigate pressure accumulation during fluid ingress, a centralized venting network is integrated into the chip architecture. Two CC architectures were evaluated: a parallel CC and a series CC. As discussed below with reference to Figures 11-13, the series CC provided more robust performance under dynamic conditions, enabling consistent CH filling and reliable stop-valve operation in contact with sweat. In both designs, each CH is connected via air conduits to a shared primary vent outlet (PVO) located at the distal end of the device, eliminating the need for individual vents at each chamber. By reducing direct exposure to ambient air and using non-permeable laminate materials, the platform suppresses evaporation while maintaining reliable bubble-free operation — which is important for low-abundance biomarkers such as cortisol.
[0134] Figure 10 schematically illustrates three alternative configurations for forming a bridge channel between two sequential microchambers of an example sample collection apparatus. Precise, self-regulated control of fluid progression without external actuation remains a central challenge in passive microfluidics. In Cap-Drop and Cap-Sweat systems, this control is achieved using capillary valves — microstructures that regulate flow by introducing controlled variations in channel geometry and surface wettability, thereby modulating local capillary pressure. By generating localized pressure barriers or thresholds, these valves govern fluid advancement within the network.Capillary valves are typically classified as SVs, burst valves, trigger valves, or retention barriers.
[0135] Each type leverages tailored interfacial energy landscapes to guide or restrain flow at specific locations within the device. While extensively applied in softlithography-based devices, capillary valve integration within laser-fabricated, multilayer microfluidics remains underdeveloped. The present disclosure demonstrates the direct incorporation of capillary valve functionalities into Cap-Sweat devices using CO2 laser-patterned PSA films and PET substrates, enabling precise flow control without secondary surface modification or deposition steps.
[0136] To systematically characterize capillary valve function, a modular testbed was designed comprising two adjacent CHs — designated CH1 and CH2 — interconnected by a narrow bridge channel that serves as the air conduit. This simplified architecture recapitulates the sequential CH arrangement and integrated ventilation structure of the Cap-Sweat system shown in box a) of Figure 10. The fluidic interfaces of interest are defined as boundary B1 , positioned between CH1 and the bridge channel, and boundary B2, located between the bridge and CH2. Boxes b), c), and d) of Figure 10 show three different testbed configurations, referred to as Config-1 , Config-2, Config-3, each evaluated in two variants: the six-layer variant of sample collection apparatus 200 of Figure 8 (which has only 5 functional layers from a capillary viewpoint, excluding the skin adhesive layer) and the four layer variant of sample collection apparatus 200A of Figure 9, all compatible with layer-by-layer laser fabrication. In the six-layer variant, both the top and bottom layers are made of hydrophilic materials, maximizing capillary force for efficient flow. In contrast, the four-layer variant replaces one of these layers with a hydrophobic material, which reduces capillary force in the main and bridge channels but allows for easier drop-casting of functional materials. The six-layer variant of Config-1 utilizes geometric constriction as the primary mechanism for modulating capillary flow. In this configuration, CH1 and CH2 are fabricated with uniform channel heights of 100 pm and are interconnected via a narrower bridge channel of equal height but reduced width. The device architecture consists of a three-layer laminate: a central hydrophobic PSA (ARcare 8939) flanked by two hydrophilic PET films (3M 9984), as shown in b)(i) of Figure 10. At boundary B1 — the interface between CH1 and the bridge channel — the fluid encounters a geometric constriction that increases hydraulic resistance and modifies the local capillary pressure, consistent with predictions from the Young-Laplace equation. However, this impedance remains below the threshold required to halt flow, allowing capillary action to proceed uninterruptedthrough B1 into the bridge. The minimum achievable bridge width is constrained to 200 pm by CO2 laser fabrication limits. A side profile of Config-1 (box b)(iii) of Figure 10) demonstrates consistent vertical dimensions across CHs and the bridge, while the frontal cross-section (box b)(iv) of Figure 10) highlights the layered construction and internal geometry governing flow behavior.
[0137] The six-layer variant of Config-2 (box c) of Figure 10) combines both geometric constriction and material heterogeneity to enhance capillary flow control. In this design, two stacked layers of hydrophobic PSA (ARcare 8939) are employed as spacer layers, enclosed between hydrophilic PET sealing films (3M 9984), as depicted in Figure 10 box c)(i). This configuration increases the number of hydrophobic surfaces at boundary B1 to three, significantly lowering local wettability and elevating the capillary entry pressure. While one hydrophilic surface remains, the dominant hydrophobic environment suppresses fluid advance and effectively slows down progression through the bridge channel. At boundary B2, the combination of reduced channel width and elevated hydrophobicity creates a burst valve behavior — fluid halts until sufficient internal pressure overcomes the retention force, after which it proceeds into CH2 (box c)(iii) of Figure 10). Although burst valves are not critical to a Cap-Sweat device's chrono-sampling functionality, this configuration demonstrates their potential utility in timing-dependent assays or fluidic gating schemes. The cross-sectional view in box c)(iv) of Figure 10 delineates the multilayer architecture and spatial arrangement of wettability contrasts, highlighting the distinct fluidic boundaries and valve control regions.
[0138] Config-3 for the six layer variant (box d) of Figure 10) implements a high-resistance architecture by embedding the bridge channel between two hydrophobic SPs, while preserving hydrophilic channel walls in CH1 and CH2. As illustrated in box d)(i) of Figure 10, this configuration effectively nullifies the forward capillary force at boundary B1 , converting it into a fully functional SV. The wettability contrast eliminates fluid ingress into the bridge channel, enabling precise flow arrest. This configuration is particularly suited for scenarios in which the bridge serves as a ventilation pathway rather than a fluid conduit. For application-relevant performance, CH1 and CH2 heights are increased to 300 pm to accommodate larger sweat volumes, while the bridgechannel height remains at 100 pm, achieved by layering three PSA sheets with distinct cut geometries (box d)(iii) of Figure 10). At boundary B2, the convergence of geometric narrowing and elevated surface energy barrier gives rise to a trigger valve, wherein flow is reinstated only after overcoming a defined threshold pressure. The front-view schematic in box d)(iv) of Figure 10 confirms full hydrophobic encapsulation at B1 and highlights the stratified assembly across spacer layers, demonstrating controlled modulation of capillary pressure through combined material and structural engineering. The four-layer variant of each configuration is formed by replacing the hydrophilic top layer (206 / 206A in Figure 10) with a hydrophobic one. In Config-1 , this change increases the number of hydrophobic surfaces at boundary B1 from two to three, but B1 still fails to function as a reliable SV. In contrast, the four-layer variant of Config-2 (box c)(iv) of Figure 10) increases BTs hydrophobic surfaces from three to four, creating a robust capillary barrier that effectively halts fluid advance. The findings demonstrate that surface wettability, rather than geometric modification, is the dominant factor governin valve functionality. Config-3 is not compatible with the four-layer architecture because it incorporates only two spacer layers in the middle layer, whereas Config-3 requires three.
[0139] The preferred bridge-channel configuration depends on the layer structure of the Cap-Sweat device. For the six-layer Cap-Sweat version, excluding the skinattachment patch, the device has five functional layers. In this configuration, the bridge channel shown in box d) of Figure 10D is preferred. In this structure, the top and bottom layers are hydrophilic, while the inner bridge channel is hydrophobic. Therefore, the bridge channel can function as a stop valve between two sequential chambers.
[0140] For the four-layer Cap-Sweat version, the skin-attachment adhesive is part of the inner channel structure and cannot be excluded. In this configuration, the bridge channel shown in box b) of Figure 10 is preferred, where the top layer is hydrophobic and the bottom layer is hydrophilic. The enclosed bridge channel is hydrophobic and can also function as a stop valve. The first bridge-channel structure in box b) of Figure 10 is less preferred when a stop-valve function is required because the bridge channel is not isolated from the top and bottom layers. Since at least one of these layers, or bothlayers, may be hydrophilic, the bridge channel does not provide an effective hydrophobic stop valve.
[0141] Figure 11 schematically illustrates (i) conventional venting of microwells; (ii) parallel passive venting of microwells; and (iii) series passive venting of microwells, along with equivalent electrical circuits (EECs). In conventional microfluidic devices for sweat collection, each CH is typically equipped with an individual air vent to facilitate displacement of trapped air during sample ingress, thereby supporting smooth, bubble-free filling.6, 29, 42-44 These vents are commonly located at the far end of each CH (Figure 11(i)) to enable local air release as sweat enters the fluidic compartment. While this approach is effective in ensuring hydraulic continuity, it introduces critical limitations when applied to wearable chrono-sampling systems. Specifically, each open vent becomes a direct site for evaporative loss, particularly under high-transpiration conditions such as physical exertion, where increased ambient temperature and skin airflow accelerate moisture evaporation. This loss is most pronounced in the first CH, which remains vented throughout the entire sampling period and is thus continuously exposed to evaporative flux. Such evaporation not only reduces the collected volume but also disrupts the temporal integrity of the sample. As water escapes through the vent, it is replaced by newly secreted sweat, leading to undesired mixing between early and late secretions within the same compartment. This backfilling effect compromises the chronological resolution of the sample array, which is essential for accurate temporal tracking of dynamic biomarker fluctuations. Moreover, evaporation-induced concentration effects may alter the apparent analyte levels, introducing systematic bias into quantitative assays. Consequently, minimizing evaporative loss is important in chrono-sampling applications, where time-resolved biomolecular fidelity directly underpins diagnostic relevance and physiological interpretation.
[0142] To circumvent the limitations associated with individual venting, the Cap-Sweat system incorporates a centralized capillary ventilation network. Two distinct architectures were designed and evaluated: a parallel CC configuration and a series CC configuration. In the parallel CC (Figure 11 (ii)), each collection CH is connected to a single PVO through dedicated microchannels that function as passive air conduits. This design replaces multiple exposed vents with a singular exit point, substantially reducingthe total venting surface area exposed to the environment and thereby mitigating evaporative losses. The extended conduit length between each CH and the PVO introduces an additional barrier to vapor diffusion, acting as a spatial buffer against ambient air intrusion. Importantly, this architecture ensures independent venting for each CH, such that the air displacement required for filling one CH does not interfere with or depend on the filling state of adjacent CHs.
[0143] In contrast, the series CC configuration (Figure 11 (iii)), arranges the air conduits such that venting is achieved sequentially, with each CH's outlet connected in a cascading manner along a common path to the PVO. In this architecture, the progression of filling inherently alters the ventilation landscape: as a downstream CH becomes occupied, it blocks the venting access of its upstream neighbor.Consequently, each CH experiences only a transient ventilation window. In the presence of an SV at the downstream end of each CH, this window begins when the advancing liquid front reaches the SV of CH x and terminates when the liquid front reaches the SV of the subsequent CH (x + 1 ). While the series configuration maintains effective chrono-integrity by supporting discrete CH filling, it imposes tighter constraints on the timing of fluid ingress. However, the predesigned hydraulic resistance of the CHs and MF, together with the series CC ventilation network, enables bubble-free filling and reliable chrono-sampling, despite the stricter temporal constraints compared with the parallel CC configuration. Both ventilation architectures eliminate the need for multiple chamber-specific (CH-specific) vents, thereby reducing direct exposure to ambient air and limiting vapor diffusion pathways. Compared with conventional designs, this centralized ventilation approach improves sample preservation, particularly for low-abundance analytes and extended-duration sampling. The inventors have determined that series passive venting of the microwells is preferred for sweat collection. In some embodiments, series passive venting may also be used in connection with the sample collection apparatus 100 of Figure 1.
[0144] In vitro tests (see Figures 12 and 12A) were performed using Cap-Sweat devices comprising 18 sequential CHs, with liquid introduced via a syringe pump at a flow rate of 18 pL min-1. The SV-to-PVO access time was quantified for both series and parallel CC configurations. The series configuration exhibited substantially shortercollection chamber (CH) access times to the primary vent outlet (PVO), thereby limiting the duration of stop-valve exposure and reducing the probability of leakage. In contrast, the parallel configuration maintains prolonged connectivity to the PVO, increasing the likelihood of unintended stop valve opening. This difference arises because, in the series CC design, each CH's connection to the PVO is terminated once the downstream chamber fills, effectively sealing the air conduit and reducing the risk of evaporation and backflow.
[0145] On the other hand, parallel CCs maintain continuous PV connectivity across all CHs, such that early-filled compartments, particularly the first CH, remain vented throughout the sampling sequence. This persistent access amplifies the chance of valve breach, especially under low contact angle conditions, thereby increasing the risk of temporal cross-contamination.
[0146] Accordingly, the series CC architecture is favored for implementation in Cap-Sweat systems. This design capitalizes on the inherent dynamics of sequential CH filling: the next CH is filled and closed before leakage can occur through the preceding SV. Although the SVs do not function as absolute barriers under moderate hydrophobicity, the time-dependent isolation intrinsic to the series CC provides sufficient containment. This dynamic gating mechanism enables reliable chrono-separation without additional actuation, material modification, or post-fabrication sealing steps, thereby preserving platform simplicity and manufacturability.
[0147] Figure 13 is a series of photographs illustrating on-body application of an example Cap-Sweat apparatus in human volunteers showing six sequential sampling zones (scale bar: 2 cm). Sweat chrono-sampling enables dynamic monitoring of biomarker fluctuations — such as cortisol, lactate, and electrolytes — offering a non-invasive window into acute physiological processes. Prior to in vivo deployment, the Cap-Sweat system's temporal fidelity was evaluated using a programmable in vitro platform with dual-color dye tracers as optical analogs of time-varying biomarker concentrations. Two chromogenic solutions — one yellow and one purple — were delivered to the device inlet via independently actuated syringe pumps. Each pump was programmed with time-dependent flow rate profiles, generating a controlled dynamic input that mimicked physiological biomarker fluctuations during exercise or stressresponse. The evolving input color served as a visually trackable surrogate for biomolecular concentration changes over time. As fluid entered the Cap-Sweat microfluidic architecture, the sequentially arranged collection CHs acted as spatiotemporal digitizers, capturing discrete aliquots of the dynamic input. This setup enabled direct assessment of temporal resolution and cross-contamination resistance under well-defined, time-varying conditions.
[0148] Following sample collection, each CH was optically imaged under controlled lighting conditions, and its contents were subjected to hue-saturation-value (HSV) analysis. The extracted chromatic data were temporally mapped and compared to the theoretical inlet profile. As shown in Figure 13A, the recorded colorimetric patterns exhibited high concordance with the programmed input sequence, demonstrating that the device accurately encoded dynamic inputs into spatially resolved sample compartments. Minor temporal shifts were observed in the initial CHs, attributable to the fluidic delay introduced by the MF channel volume, which acts as a temporal buffer between the inlet and the first CH. Importantly, no evidence of dye dispersion or inter-CH mixing was detected beyond this initial lag phase, confirming the effectiveness of the capillary barrier valves in isolating consecutive fluid volumes. The precision of temporal sampling improved progressively across downstream CHs, indicating steady-state operation and minimal influence from pulsatile flow irregularities. The results validate the chrono-sampling capability of the Cap-Sweat system under physiologically relevant flow conditions, demonstrating accurate discretization of dynamic input concentrations without external actuation.
[0149] Following successful in vitro characterization, Cap-Sweat was deployed in vivo to assess its performance under physiologically relevant conditions involving moderate-intensity physical exertion. For all in vivo experiments, a six-layer Cap-Sweat version incorporating a series CC architecture with Config-3 SVs was used, as this configuration provides the larger per-CH sweat volume required for ELISA-based cortisol analysis. Human subjects (n = 3) performed treadmill exercise at a controlled pace of 5.5-6.5 km / h (1.5% incline), a regimen previously shown to induce thermoregulatory eccrine sweating without causing excessive motion artifacts or sweat pooling. This specific protocol was chosen to ensure consistent sweat generationacross subjects while minimizing factors that could disrupt capillary filling, such as vigorous limb movement or excessive gland pressure. Exercise sessions lasted 12-16 min, corresponding to sustained eccrine activation under moderate workload and matching the full 18-CH chrono-sampling window (40-60 s per CH). This ensured that each chamber captured newly secreted sweat while avoiding thermal fatigue and preserving steady-state physiological output for cortisol evaluation.
[0150] To ensure sufficient volume for downstream analysis, samples from every three CHs — corresponding to -2-3 min of sweat collection — were pooled to yield a 9 pL aliquot for ELISA-based cortisol quantification. Figure 13B displays representative cortisol trajectories from three participants, each revealing unique temporal dynamics. All participants showed a pronounced early peak within the first 2-3 min of physical exertion, followed by a drop and subsequent fluctuations. This early cortisol surge likely reflects rapid transdermal diffusion driven by steep plasma-to-sweat concentration gradients or the release of preformed cortisol from sweat glands under acute sympathetic stimulation. The fluctuating patterns that follow suggest pulsatile secretion dynamics of the hypothalamic-pituitary-adrena (HPA) axis and / or reabsorptive processes within the sweat duct. While such dynamic trends are typically missed in low-resolution sampling methods, the sub-minute chrono-sampling enabled by Cap-Sweat reveals fine-grained hormonal variations relevant to acute stress physiology. Notably, when the cortisol profiles were transformed into the frequency domain, low-frequency oscillatory components (-0.05-0.15 Hz) emerged, consistent with known ultradian rhythms of cortisol regulation described in plasma studies. This suggests that the Cap-Sweat system can resolve meaningful physiological patterns associated with stress adaptation and neuroendocrine pulsatility — offering a wearable platform for continuous endocrine monitoring beyond conventional static assays.
[0151] Figure 13C presents sweat-rate data across six zones during the exercise period for three human subjects (Sb), where each zone comprises three consecutive CHs connected in series (total volume: 9 pL). Analyzing sweat volume at the level of individual CHs, rather than as zone-aggregated measurements, provides improved temporal resolution, with observed trends consistent with physiological patterns reported in the literature. Because each CH stores a fixed volume, variations in sweatsecretion rate affect only the filling time and not the measured biomarker concentration. Accordingly, differences in cortisol levels across zones (Figure 13B), quantified by ELISA, reflect genuine temporal concentration dynamics rather than artifacts arising from sweat-rate variability. This decoupling of secretion rate from analyte concentration enables Cap-Sweat to operate as a dual-mode lab-on-chip platform for simultaneous assessment of thermoregulation and stress response. The system achieves <3 min temporal resolution per CH through passive capillary transport, eliminating the need for active pumping. This architecture further supports integration of sweat-rate modeling with chrono-sampled biomarker data, providing a foundation for estimating secretion kinetics, gland responsiveness, and dynamic stress load indices in future wearable applications.
[0152] Beyond acute exercise studies, the Cap-Sweat's platform architecture is extensible to multi-hour and multiplexed biomarker tracking. Its passive capillary elements and modular CHs support delayed filling strategies, enabling longitudinal studies without continuous exertion. This opens new avenues for use in sedentary or sleep-monitoring contexts, psychological health surveillance, and occupational fatigue assessment. Furthermore, integration of naked-eye sensors (e.g., colorimetric strips) or embedded electrochemical transducers within individual sampling units can provide instant readouts of pH, glucose, or lactate fluctuations — mirroring concepts established in wearable diagnostic platforms.50 Such visual or digital readouts could inform users of hourly metabolic changes, thereby enhancing self-monitoring and preventative care.
[0153] While cortisol is widely used for non-invasive stress assessment, its response kinetics (10-30 min) primarily reflect downstream activation of the hypothalamic-pituitary-adrenal (HPA) axis and may therefore miss rapid-onset stressors occurring on seconds-to-minutes timescales. The high temporal resolution of the Cap-Sweat system provides a foundation for detecting acute-phase sweat biomarkers (e.g., neuropeptides, catecholamines, and cytokines) and for integrating immunosensors that enable simultaneous monitoring of both acute and chronic stress responses. Such capability could improve attribution of physiological triggers and differentiation of stress response types. Acute mediators, including calcitonin gene-related peptide (CGRP), substance P, and interleukin-6 (IL-6), have been associatedwith eccrine secretion and peripheral neurogenic inflammation and may accumulate in superficial tissue layers accessible to wearable sweat sensors. Incorporating corresponding sensing elements into Cap-Sweat microchannels or detection zones could enable continuous electrochemical or optical monitoring of dermal neurochemical activity.
[0154] The Cap-Sweat system's compact design, which does not require external adhesives, enables placement on multiple body sites (e.g., forehead, forearm, chest, upper back) without disrupting natural sweat flow. This supports simultaneous multipatch deployment for spatial mapping of biomarker dynamics across anatomical regions. Given regional differences in sweat gland density and subtype distribution, multi-site chrono-sampling can reveal site-specific variations in sweat composition, secretion rate, and biomarker flux. Capturing this spatial heterogeneity may enhance diagnostic interpretation and facilitate identification of biomarkers enriched within localized skin microenvironments. By enabling site-resolved biomarker profiling, multipatch deployment positions Cap-Sweat as a versatile platform for advancing personalized diagnostics and improving our understanding of regional dermal physiology.
[0155] It will be appreciated that numerous specific details are set forth in order to provide a thorough understanding of the exemplary embodiments described herein. However, it will be understood by those of ordinary skill in the art that the embodiments described herein may be practiced without these specific details. In other instances, well-known methods, procedures and components have not been described in detail so as not to obscure the embodiments described herein. Furthermore, this description is not to be considered as limiting the scope of the embodiments described herein in any way, but rather as merely describing implementation of the various example embodiments described herein.
[0156] The description provides many example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subjectmatter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0157] As will be apparent to those skilled in the art in light of the foregoing disclosure, many alterations and modifications are possible to the methods and systems described herein. While a number of exemplary aspects and embodiments have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations as may reasonably be inferred by one skilled in the art. The scope of the claims should not be limited by the embodiments set forth in the examples, but should be given the broadest interpretation consistent with the foregoing disclosure.
[0158] The present disclosure may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive.
Claims
Claims1. An apparatus for separating a liquid sample into a plurality of individual droplets, the apparatus comprising:a bottom layer and a top layer, each constructed from a hydrophilic material, and a plurality of adhesive layers disposed between the bottom layer and the top layer, each adhesive layer constructed from a hydrophobic material, wherein:the top layer has openings formed therein defining a sample inlet and a vent; the plurality of adhesive layers have openings formed therein defining a microfluidic circuit comprising:an inlet chamber in fluid communication with the sample inlet;an outlet chamber in fluid communication with the vent;a main flow channel connected between the inlet chamber and the outlet chamber;a plurality of microwells, each microwell having a first end and a second end, the first end connected to the main flow channel; anda passive venting channel network providing fluid communication between the second end of each of the plurality of microwells and a downstream portion of the main flow channel between a last microwell of the plurality of microwells and the outlet chamber.
2. The apparatus of claim 1 wherein the main flow channel comprises a bubble trap between the plurality of microwells and the downstream portion.
3. The apparatus of claim 1 or claim 2 wherein the second end of each of the plurality of microwells is connected to the passive venting channel network through a stop valve.
4. The apparatus of any one of claims 1 to 3 comprising a wicking pad disposed within the outlet chamber.
5. The apparatus of any one of claims 1 to 4 wherein the plurality of adhesive layers comprise a lower adhesive layer in contact with the bottom layer, an upper adhesive layer in contact with the top layer, and at least one intermediate adhesive layer between the upper and lower adhesive layers.
6. The apparatus of claim 5 wherein the passive venting channel network is defined by openings in only the at least one intermediate adhesive layer.
7. The apparatus of claim 5 or claim 6 wherein, for each microwell, a distance between the first end and the second end is shorter in the upper adhesive layer than in the lower adhesive layer and the at least one intermediate adhesive layer.
8. The apparatus of any one of claims 1 to 7 wherein the microwells on each side of the main channel are arranged in sequence, and the passive venting channel network comprises a trigger valve connected between the second ends of adjacent microwells in each sequence, such that the microwells on each side of the main channel are filled sequentially.
9. The apparatus of any one of claims 1 to 8 wherein the top layer has an opening defining a second inlet.
10. The apparatus of any one of claims 1 to 9 wherein the top layer has openings defining a plurality of vents, and the microfluidic circuit comprises a plurality of main flow channels, each having a plurality of microwells extending therefrom and an associated outlet chamber in fluid communication with one of the plurality of vents.
11. The apparatus of any one of claims 1 to 10, wherein the microfluidic circuit further comprises a capillary pump formed by interconnected channels having differing surface energies and geometries, the capillary pump being configured to passively control timing and rate of fluid movement through the microfluidic circuit without external pressure or actuation.
12. The apparatus of claim 11 , wherein the capillary pump comprises at least one high capillary force channel connected to a retention region, the high capillary force channel and the retention region cooperating to regulate fluid movement through defined capillary pressure gradients to enable staged progression of the liquid sample.
13. The apparatus of any one of claims 1 to 12, wherein the microfluidic circuit further comprises one or more passive valve structures selected from retention valves, burst valves, stop valves, and trigger valves, each passive valve structure being defined by a change in channel geometry or surface property and being configured to block or delay fluid flow until a predetermined pressure threshold is reached.
14. The apparatus of claim 13, wherein at least one of the passive valve structures is formed by partially or fully cutting through one or more of the plurality of adhesive layers to create a depth-based or material-based transition that determines a bursting pressure for fluid flow.
15. The apparatus of any one of claims 1 to 14, wherein each of the plurality of microwells is connected to the downstream portion of the main flow channel through a flow control interface formed by a junction of channels having differing cross-sectional shapes, surface energies, or material properties to regulate droplet separation and timing.
16. The apparatus of any one of claims 1 to 15, wherein one or more channels of the microfluidic circuit are formed by partially cutting through at least one of the plurality of adhesive layers without penetrating a full thickness of that adhesive layer.
17. The apparatus of any one of claims 1 to 16, wherein the apparatus is fabricated using a multilayer lamination process including the bottom layer, the top layer, and the plurality of adhesive layers defining the microfluidic circuit, the process being compatible with roll-to-roll manufacturing using polymer sheets and adhesive films.
18. The apparatus of any one of claims 1 to 17, wherein the apparatus is configured as a digital loop-mediated isothermal amplification cartridge comprising optically transparent, non-autofluorescent, and thermally stable polymer layers, the microwellsbeing configured for compartmentalised amplification and for detection by an external fluorescence detection system.
19. The apparatus of any one of claims 1 to 18, wherein the passive venting channel network is arranged in a series or a parallel configuration and the microfluidic circuit comprises at least two sample inlets and at least two outlet chambers to enable sequential or simultaneous delivery of multiple fluid phases.
20. The apparatus of claim 19, wherein, in the series configuration, the passive venting channel network comprises pathways of differing lengths or flow resistances connected to the second ends of the microwells to delay venting and control timing of microwell filling.
21. The apparatus of any one of claims 1 to 20, wherein the plurality of microwells are pre-functionalised with at least one reagent selected from antibodies, enzymes, aptamers, peptides, and primers to enable a chemical or biological reaction within the microwells.
22. The apparatus of any one of claims 1 to 21 , wherein the microfluidic circuit further comprises a serial dilution module including branched channels of differing geometries configured to generate concentration gradients across the plurality of microwells.
23. The apparatus of claim 22, wherein fluid movement and mixing within the microfluidic circuit occur solely by capillary action and channel geometry without external pumps or actuators.
24. The apparatus of any one of claims 1 to 23, wherein the top layer is reversibly bonded relative to at least one of the plurality of adhesive layers to permit access to the microwells after processing.
25. The apparatus of any one of claims 1 to 24, wherein the sample inlet comprises a fibre-based wick configured to collect eccrine sweat and deliver the eccrine sweat to the inlet chamber while reducing formation of gas bubbles.
26. The apparatus of any one of claims 1 to 25, wherein the microfluidic circuit comprises one or more timing channels configured to sequentially direct fluid into respective microwells over time.
27. The apparatus of any one of claims 1 to 26, wherein the apparatus is incorporated into a wearable patch comprising a flexible substrate and optionally one or more electronic or optical components configured for data acquisition or transmission.
28. The apparatus of any one of claims 1 to 27, wherein the apparatus is incorporated into a swallowable capsule configured to sample gastrointestinal fluid and divide the fluid into droplets within the plurality of microwells.
29. The apparatus of any one of claims 1 to 28, wherein the microfluidic circuit is enclosed between the top layer and the bottom layer to reduce evaporation during incubation or thermal processing.
30. The apparatus of any one of claims 1 to 29, wherein the second end of each microwell is connected to the passive venting channel network through a hydrophobic valve configured to permit pressure equalisation while limiting evaporation.
31. The apparatus of any one of claims 1 to 30, wherein the microfluidic circuit is modelled using an electrical analogue comprising resistive, capacitive, and pressure elements to predict flow behaviour.
32. The apparatus of any one of claims 1 to 31 , wherein the microfluidic circuit is designed or optimised using an artificial intelligence system trained on empirical or simulated flow data to generate or refine channel geometries.
33. The apparatus of any one of claims 1 to 32, wherein the microfluidic circuit is configured to perform a multi-phase assay by sequentially delivering reagents into the microwells using capillary-driven timing elements.
34. The apparatus of any one of claims 1 to 33, wherein the microwells are configured to contain cells or cell clusters within droplets or matrices for biological analysis.
35. The apparatus of any one of claims 1 to 34, wherein each microwell is configured to be sealed after filling by at least one of an oil layer, a hydrophobic barrier, or an adhesive membrane.
36. The apparatus of any one of claims 1 to 35, wherein fluid entering through the sample inlet is distributed among the microwells through branch channels configured to provide substantially uniform filling.
37. The apparatus of any one of claims 1 to 36, wherein the sample inlet comprises a porous fibre element configured to filter debris or cells and to regulate flow prior to entry into the inlet chamber.
38. The apparatus of any one of claims 1 to 37, wherein the microfluidic circuit further comprises a passive mixing region disposed between the inlet chamber and the main flow channel, the passive mixing region including geometric features configured to mix fluid by advection or dispersion.
39. The apparatus of any one of claims 1 to 38, wherein the passive mixing region is configured to mix multiple fluid components introduced through the sample inlet prior to distribution to the microwells.
40. The apparatus of any one of claims 1 to 39, wherein the top layer defines at least three inlets including a first inlet for a biological sample, a second inlet for a reagent, and a third inlet configured to introduce an initiator fluid that controls timing of fluid entry into the microfluidic circuit.
41. The apparatus of any one of claims 1 to 40, wherein the main flow channel is configured to generate a concentration gradient of at least two fluids along a length of the main flow channel.
42. The apparatus of any one of claims 1 to 41 , wherein the apparatus is configured to allow detection of signals from the microwells using a portable detection device.
43. The apparatus of any one of claims 1 to 42, wherein at least one microwell comprises two inlet ports and an associated vent configured to permit filling of the microwell with two fluids.
44. The apparatus of any one of claims 1 to 43, wherein the microfluidic circuit comprises a recirculating loop configured to permit reversible fluid flow through at least one microwell.
45. The apparatus of any one of claims 1 to 44, wherein each microwell includes a capillary structure configured to isolate fluid within the microwell upon reaching a predetermined condition.
46. The apparatus of any one of claims 1 to 45, wherein at least one layer of the microfluidic circuit is formed from a semipermeable material configured to permit selective passage of gases or small molecules.
47. The apparatus of any one of claims 1 to 46, wherein adjacent microwells are separated by a material configured to permit molecular diffusion while restricting bulk fluid flow.
48. The apparatus of any one of claims 1 to 47, wherein the sample inlet is configured to reduce hydrostatic pressure effects such that fluid entry is governed predominantly by capillary action.
49. The apparatus of any one of claims 1 to 48, wherein the microwells have non-rectangular shapes selected from circular, oval, trapezoidal, or asymmetric shapes.
50. The apparatus of any one of claims 1 to 49, wherein the microwells are shaped to promote aggregation of cells and the top layer is removable to allow retrieval of the cells.
51. The apparatus of any one of claims 1 to 50, wherein the apparatus is configured for operation on a tilting platform to induce bidirectional flow between the inlet chamber and the outlet chamber.
52. The apparatus of any one of claims 1 to 51 , wherein the plurality of microwells comprises between 5,000 and 10,000 microwells configured to receive droplets from the main flow channel.
53. The apparatus of any one of claims 1 to 52, wherein the apparatus is configured to be used in a centrifuge to assist filling of the microwells while maintaining capillary-driven flow.
54. A method of collecting a biological sample, the method comprising providing the apparatus according to any one of claims 1 to 53 and delivering a biological fluid to the sample inlet such that the biological fluid is divided into droplets within the plurality of microwells.
55. The method of claim 54, further comprising collecting the droplets from the plurality of microwells.
56. The method of claim 54 or 55, further comprising delivering an oil into the microfluidic circuit to fill the main flow channel and isolate the droplets within the microwells.
57. A method of controlling delivery of multiple fluid phases using the apparatus of any one of claims 1 to 53, the method comprising introducing at least two fluid phases through respective inlets and directing the fluid phases through the microfluidic circuit to control timing of entry into the microwells.
58. The method of claim 57, wherein movement of the fluid phases is governed by capillary pressure gradients established by channel geometry, surface energy, and valve configuration without use of external flow drivers.
59. A microfluidic system for separating a liquid sample into droplets, comprising: the apparatus according to any one of claims 1 to 53; andat least one detection system configured to detect a signal generated from droplets contained in the plurality of microwells.
60. The system of claim 59, wherein the detection system comprises an optical detection system configured to detect fluorescence, colourimetric, or luminescent signals from the microwells.
61. The system of claim 59 or claim 60, wherein the detection system comprises a portable device including a smartphone, handheld reader, or compact imaging system.
62. The system of any one of claims 59 to 61 , further comprising a processing module configured to analyse signals detected from the microwells to quantify a biological or chemical target.
63. The system of any one of claims 59 to 62, wherein the processing module comprises a machine-learning model configured to interpret assay results or classify sample characteristics.
64. The system of any one of claims 59 to 63, further comprising a user interface configured to display analysed results or transmit the analysed results to a remote system.
65. The system of any one of claims 59 to 64, wherein the apparatus and the detection system are integrated into a portable diagnostic platform.
66. A method of analysing a liquid sample, the method comprising:providing the apparatus according to any one of claims 1 to 53;delivering the liquid sample to the sample inlet; andallowing the liquid sample to flow through the microfluidic circuit by capillary action so as to divide the liquid sample into droplets in the plurality of microwells.
67. The method of claim 66, further comprising detecting a signal generated from at least one droplet in the plurality of microwells.
68. The method of claim 67, wherein detecting the signal comprises fluorescence detection.
69. The method of any one of claims 66 to 68, further comprising analysing the detected signal to determine a concentration of a target analyte.
70. The method of any one of claims 66 to 69, wherein the liquid sample comprises a biological fluid selected from blood, sweat, saliva, urine, or gastrointestinal fluid.
71. The method of any one of claims 66 to 70, wherein each droplet within the microwells contains a reagent configured to react with a target analyte present in the liquid sample.
72. The method of any one of claims 66 to 71, further comprising performing an amplification reaction within at least one microwell.
73. A method of controlling fluid delivery in a capillary-driven microfluidic circuit, the method comprising:providing the apparatus according to any one of claims 1 to 53;introducing a first fluid through a first inlet and a second fluid through a second inlet; and allowing the first fluid and the second fluid to flow through the microfluidic circuit, wherein flow timing and sequence are determined by channel geometry, surface properties, and passive valve structures of the microfluidic circuit.
74. The method of claim 73, wherein at least one of the first fluid and the second fluid is delayed by a passive valve until a pressure threshold is reached.
75. The method of claim 73 or claim 74, further comprising introducing a third fluid configured to trigger flow of at least one of the first fluid or the second fluid.7Q. The method of any one of claims 73 to 75, wherein the first fluid and the second fluid are combined within a mixing region prior to distribution into the microwells.
77. The method of any one of claims 73 to 76, wherein the first fluid and the second fluid form a gradient along the main flow channel.
78. A method of isolating droplets in a microfluidic device, the method comprising: performing the method of any one of claims 66 to 72; andintroducing a third fluid into the main flow channel to isolate droplets contained within the microwells.
79. The method of claim 78, wherein the third fluid comprises an immiscible fluid.
80. The method of claim 78 or claim 79, wherein the third fluid comprises an oil.
81. The method of any one of claims 78 to 80, wherein the droplets are maintained in an isolated state for incubation or storage.
82. The method of any one of claims 66 to 72, wherein the droplets are used for singlecell analysis.
83. The method of any one of claims 66 to 72, wherein the droplets are used for digital nucleic acid amplification.
84. The method of any one of claims 66 to 72, wherein the droplets are used for chemical reaction screening or drug testing.
85. An apparatus for collecting sweat samples from a subject, the apparatus comprising:a bottom layer and a top layer, each constructed from a hydrophilic material, and a plurality of adhesive layers disposed between the bottom layer and the top layer, each adhesive layer constructed from a hydrophobic material, wherein:the top layer has an opening formed therein defining a sweat sample inlet;one of the plurality of adhesive layers defines a primary vent outlet; the plurality of adhesive layers have openings formed therein defining a microfluidic circuit comprising:an inlet chamber in fluid communication with the sample inlet;an outlet chamber in fluid communication with the primary vent outlet;a main flow channel connected between the inlet chamber and the outlet chamber; and,a plurality of microchannels, each microchannel having a first end and a second end, the first end connected to the main flow channel, and the second end connected to the primary vent outlet through a capillary valve.
86. The apparatus of claim 85, wherein the second ends of the plurality of microchannels are connected in parallel to the primary vent outlet.
87. The apparatus of claim 85, wherein the second ends of the plurality of microchannels are connected in series to the primary vent outlet.
88. The apparatus of any one of claims 85 to 87, wherein the top layer has a skin adhesive applied thereto configured to removeably attach the apparatus to the subject’s skin.
